Rapport Therapeutics, Inc. (RAPP) stock
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.15+0.30 (+1.16%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
Rapport Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Rapport Therapeutics's enterprise value was $859.67M on Nov 11, 2026, against $902.69M a year earlier. Over the last 3 years it ranged from -$52.72M to $1.90B, with a median of $754.97M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $859.67M | -7.8% |
| 2025 | Dec 31, 2025 | $932.71M | +184.2% |
| 2024 | Dec 31, 2024 | $328.17M | – |
See a number that looks wrong?